comparemela.com

Latest Breaking News On - Phase clinical development at pfizer oncology - Page 1 : comparemela.com

Viracta Therapeutics Appoints Darrel P Cohen, M D , Ph D as Chief Medical Officer

SAN DIEGO, Aug. 07, 2023 Viracta Therapeutics, Inc. , a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients.

Ashleigh barretoDarrelp cohenMark rotheraKathy vincentViracta therapeutics incGreig communicationsGeorgetown university medical centerBiosight pharmaceuticalsPhase clinical development at pfizer oncologyLeadership teamHead of clinical developmentGlobenewswire incDuke university medical centerCell therapy at athenex incHead of investor relations corporate communicationsBoston university school of medicine

Athenex Appoints Darrel P Coh - GuruFocus com

GuruFocus Article or News written by GuruFocusNews and the topic is about:

Daniel langJohnson lauKurt gunterCaileigh doughertyDarrelp cohenInvestor relations departmentBiosight pharmaceuticalsBoston university school of medicineMedicine at georgetown university medical centerAthenex incPhase clinical development at pfizer oncologyHead of clinical developmentHematology oncology at duke university medical centerChief medical officerCell therapyChief executive officer

Athenex Appoints Darrel P Cohen, MD, PhD as Chief Medical

BUFFALO, N.Y., June 08, 2022 (GLOBE NEWSWIRE) Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery,.

Daniel langJohnson lauKurt gunterCaileigh doughertyDarrelp cohenInvestor relations departmentBiosight pharmaceuticalsBoston university school of medicineMedicine at georgetown university medical centerAthenex incPhase clinical development at pfizer oncologyHead of clinical developmentHematology oncology at duke university medical centerChief medical officerCell therapyChief executive officer

vimarsana © 2020. All Rights Reserved.